Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma

American Journal of Pathology

Volumn 153, Issue 1, 1998, Pages 263-269

  Liu, Ni ^a   Furukawa, Toru ^c   Kobari, Masao ^c   Tsao, Ming Sound ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; CYCLIN DEPENDENT KINASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; KERATINOCYTE GROWTH FACTOR; MESSENGER RNA; PROTEIN P16; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR ALPHA RECEPTOR; TYROSINE KINASE RECEPTOR; VASCULOTROPIN RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; PANCREAS CARCINOMA; PANCREAS DUCT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031847421     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65567-8     Document Type: Article

References (48)

1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1997. CA Cancer J Clin 1997, 47:5-27
2. Kloppel G: Pathology of nonendocrine pancreatic tumours. The Pancreas: Biology, Pathobiology, and Disease. Edited by Go VLW, Dimagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA. New York, Raven Press, 1993, pp 871-897
3. Baumel H, Huguier M, Manderscheid JC, Fabre JM, Houry S, Fagot H: Results of resection for cancer of exocrine pancreas: a study from the French Association of Surgery. Br J Surg 1994, 81:102-107
4. Murr MM, Sarr MG, Oishi AJ, van Heerden JA: Pancreatic cancer. CA Cancer J Clin 1994, 44:304-318
5. DiGiuseppe JA, Hruban RH: Pathobiology of cancer of the pancreas. Semin Surg Oncol 1995, 11:87-96
6. Motojima K, Urano T, Nagata Y, Shiku H, Tsunoda T, Kanematsu T: Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma. Am J Gastroenterol 1991, 86:1784-1788
7. Hruban RH, van Mansfeld ADM, Offerhaus GJA, van Weering DHJ, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL: K-ras oncogene activation in adenocarcinoma of the human pancreas. Am J Pathol 1993, 143:545-554
8. Pellegata NS, Sessa F, Renault B, Bonato M, Leone BE, Solcia E, Ranzani GN: K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumours progress through different genetic lesions. Cancer Res 1994, 54:1556-1560
9. DiGiuseppe JA, Hruban RH, Goodman SN, Polak M, van den Berg FM, Allison DC, Cameron JL, Offerhous JA: Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 1994, 101:684-688
10. Sinicrope FA, Evans DB, Leach SD, Cleary KR, Fenoglio CJ, Lee JJ, Abbruzzese JL: bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome. Clin Cancer Res 1996, 2:2015-2022
11. Friess H, Yamanaka Y, Buchler M, Ebert M, Berger H, Gold LI, Korc M: Enhanced expression of transforming growth factor-β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993, 105:1846-1856
12. Yamanaka Y, Friess H, Buchler M, Berger HG, Uchida E, Onda M, Kobrin MS, Korc MS: Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 1993, 53:5289-5296
13. Lei S, Appert HE, Nakata B, Domenico DR, Kim K, Howard JM: Overexpression of HER2/neu oncogene in pancreatic cancer correlates with shortened survival. Int J Pancreatol 1995, 17:15-21
14. Shimoyama S, Gansauge F, Gansauge S, Negri G, Oohara T, Berger HG: Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res 1996, 56:2703-2706
15. Pignatelli M, Ansari TW, Gunter P, Liu D, Hirano S, Takeichi M, Kloppel G, Lemoine NR: Loss of membrane E-cadherin expression in pancreatic cancer, correlation with lymph node metastasis, high grade, and advanced stage. J Pathol 1994, 174:243-248
16. Lemoine NR, Lobresco M, Leung H, Barton C, Hughes CM, Prigent SA, Gullick WJ, Kloppel G: The erbB-3 gene in human pancreatic cancer. J Pathol 1992, 168:269-273
17. Korc M, Chandrasekar B, Yamanaka Y, Friess H, Buchler M, Beger HG: Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor-alpha. J Clin Invest 1992, 90:1352-1360
18. Lemoine NR, Hughes CM, Barton CM, Poulsom R, Jeffery RE, Kloppel G, Hall PA, Gullick WJ: The epidermal growth factor receptor in human pancreatic cancer. J Pathol 1992, 166:7-12
19. Hall PA, Hughes CM, Staddon SL, Richman PI, Gullick WJ, Lemoine NR: The c-erbB-2 proto-oncogene in human pancreatic cancer. J Pathol 1990, 161:195-200
20. Yamanaka Y, Friess H, Kobrin MS, Buchler M, Kunz J, Beger HG, Korc M: Overexpression of HER2/neu oncogene in human pancreatic carcinoma. Hum Pathol 1993, 24:1127-1134
21. Day JD, DiGiuseppe JA, Yeo C, Lai-Goldman M, Anderson SM, Goodman SN, Kern SE, Hruban RH: Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. Hum Pathol 1996, 27:119-124
22. Tsutsumi M, Yasui W, Naito A, Ohashi K, Kobayashi E, Noguchi O, Horiguchi K, Okita S, Tsujiuchi T, Kitada H, Ishikawa O, Tahara E, Konishi Y: Expression of cripto in human pancreatic tumors. Jpn J Cancer Res 1994, 85:118-121
23. Friess H, Yamanaka Y, Buchler M, Kobrin M, Tahara E, Korc M: Cripto, a member of the epidermal growth factor family, is overexpressed in human pancreatic cancer and chronic pancreatitis. Int J Cancer 1994, 56:668-674
24. Ebert M, Yokoyama M, Kobrin MS, Friess H, Lopez ME, Buchler MW, Johnson GR, Korc M: Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res 1994, 54:3959-3962
25. Kobrin MS, Funatomi H, Friess H, Buchler MW, Stathis P, Korc M: Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem Biophys Res Commun 1994, 202:1705-1709
26. Ebert M, Yokoyama M, Friess H, Buchler MW, Korc M: Co-expression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res 1994, 54:5775-5778
27. Barton CM, Hall PA, Hughes CM, Gullick WJ, Lemoine NR: Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol 1991, 163:111-116
28. Furukawa T, Duguid WP, Kobari M, Matsuno S, Tsao M-S: Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis. Am J Pathol 1995, 147:889-895
29. Oikawa T, Hitomi J, Kono A, Kaneko E, Yamaguchi K: Frequent expression of genes for receptor tyrosine kinases and their ligands in human pancreatic cancer cells. Int J Pancreatol 1995, 18:15-23
30. Di Renzo MF, Olivero PM, Comoglio PM, Lemoine NR: Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 1995, 55:1129-1138
31. Furukawa T, Duguid WP, Rosenberg L, Viallet J, Galloway DA, Tsao M-S: Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol 1996, 148:1763-1770
32. Kobari M, Hisano H, Matsuno S, Sato T, Kan M, Tachibana T: Establishment of six human pancreatic cancer cell lines and their sensitivities to anti-tumor drugs. Tohoku J Exp Med 1986, 150:231-248
33. Tsao M-S, Zhu H, Viallet J: Autocrine growth loop of the epidermal growth factor receptor in normal and immortalized human bronchial epithelial cells. Exp Cell Res 1996, 223:268-273
34. Rodrigues GA, Naujokas MA, Park M: Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing. Mol Cell Biol 1991, 11:2962-2970
35. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309
36. Ciccodicola A, Dono R, Obici S, Simeone A, Zollo M, Persico MG: Molecular characterization of a gene of the "EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J 1989, 8:1987-1991
37. Liu Q, Van Y-X, McClure M, Nakagawa H, Fujimura F, Rustgi AK: MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines. Oncogene 1995, 10:619-622
38. Schutte M, Hruban RH, Geradts J, Maynard M, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, Herman JG: Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 1997, 57:3126-3130
39. Hahn SA, Seymour AB, Shamsul Hoque ATM, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 1995, 55:4670-4675
40. Moskaluk CA, Hruban RH, Kern SE: p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997, 57:2140-2143
41. Hu G, Liu W, Mendelsohn J, Ellis LM, Radinsky R, Andreeff M, Deisseroth AB: Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma ceils J Natl Cancer Inst 1997, 89:1271-1276
42. Beerli RR, Hynes NE: Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J Biol Chem 1996, 271:6071-6076
43. Shoyab M, Plowman GD, McDonald VL, Bradley JG, Todaro GJ: Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science 1989, 243:1074-1076
44. Plowman GD, Green JM, McDonald VL, Neubauer MG, Disteche CM, Todaro GJ, Shoyab M: The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol Cell Biol 1990, 10:1969-1981
45. Earp HE, Dawson TL, Li X, Yu H: Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implication for breast cancer research. Breast Cancer Res Treat 1995, 35:115-132
46. Ebert M, Yokoyama M, Kobrin MS, Friess H, Lopez ME, Buchler MW, Johnson GR, Korc M: Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res 1994, 54:3959-3962
47. Siddiqi I, Funatomi H, Kobrin MS, Friess H, Buchler MW, Korc M: Increased expression of keratinocyte growth factor in human pancreatic cancer. Biochem Biophys Res Commun 1995, 215:309-315
48. Itakura J, Ishiwata T, Friess H, Fujii H, Matsumoto Y, Büchler MW, Korc M: Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res 1997, 3:1309-1316